Research showed that patients who lose weight on GLP-1 agonists frequently experience muscle mass loss. Obesity experts share ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug ...

Adverse events were frequent, and most were gastrointestinal-related, including nausea, vomiting, diarrhea, constipation ...

The 7.1-magnitude earthquake struck Dingri County in Tibet at 9:05 am local time. At least 95 people have been killed. How ...

Three GLP-1 drugs are best at helping obese and overweight people drop weight, including one that hasn’t yet been ap ...

Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...

These drugs, called glucagon-like peptide-1 receptor agonists (GLP-1 RAs), work in several different ways to help people lose ...

The drugs initially were approved as a treatment for type 2 diabetes because they help lower blood sugar levels. But subsequent studies found that GLP-1 drugs also help people lose weight.

JPMorgan's annual survey of 40 executives shows that coverage of popular weight-loss drugs continues to slowly increase ...

Weight loss ... 1 receptor (GLP-1R) agonists (you may know them under such names as Ozempic, Wegovy, Saxenda or Zepbound), these types of drugs have actually been around for about 20 years, having ...